Affiliation: Karolinska University Hospital
- Capecitabine as third line therapy in patients with advanced colorectal cancerMichael Gubanski
Department of Oncology, Karolinska University Hospital Huddinge, Stockholm, Sweden
Acta Oncol 44:236-9. 2005..in patients with irinotecan- and oxaliplatin-combination resistant advanced colorectal cancer...
- Randomized phase II study of sequential docetaxel and irinotecan with 5-fluorouracil/folinic acid (leucovorin) in patients with advanced gastric cancer: the GATAC trialMichael Gubanski
Department of Oncology, Karolinska University Hospital at Södersjukhus, Sjukhusbacken 10, SE 118 83, Stockholm, Sweden
Gastric Cancer 13:155-61. 2010..We compared sequential administration of docetaxel and irinotecan, both in combination with infused 5-fluorouracil/leucovorin (5-Fu/Lv), and randomly assigned patients to start with either of the two...
- Advances in the treatment of patients with gastric adenocarcinomaTheodoros Foukakis
Department of Oncology, Karolinska University Hospital Södersjukhuset, Stockholm, Sweden
Acta Oncol 46:277-85. 2007..However, the response rates have generally been moderate and there is no consensus on the optimal combination of cytotoxic agents and the potential role of more recently developed "targeted therapies"...